Organisation paid for research Program year 2021 Source: CMS Open Payments

Advncd Medcl Rsrch PC

Neither a doctor nor a teaching hospital

Research payments

$20,258

38 payments

Through program year 2021, Advncd Medcl Rsrch PC is reported as receiving $20,258 in research payments, across 38 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2021	Research	$517	1
2020	Research	$8,088	11
2019	Research	$11,652	26

Breakdown

Who paid Research payments · program years 2019–2021

Boehringer Ingelheim Pharma GmbH & Co.KG $8,998 25 payments
Boehringer Ingelheim International GmbH $8,893 8 payments
Boehringer Ingelheim Pharmaceuticals, Inc. $2,367 5 payments

Studies the money was for Research payments · program years 2019–2021

BI 730357 PoCC and dose-ranging in Psoriasis $12,275 26 payments
Dose finding Trial in PPP (Phase II) $4,730 5 payments
BI 730357 Psoriasis Long Term Extension $1,726 2 payments
BI 730357 - Psoriasis Long-Term Extension $885 2 payments
Dose finding Trial in PPP Phase II $557 1 payment
BI 730357 PoCC and dose ranging in Psoriasis $83 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.